Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
about
Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
description
scientific article published on 06 March 2019
@en
name
Randomised phase 3 trial: tego ...... ents with erosive oesophagitis
@en
type
label
Randomised phase 3 trial: tego ...... ents with erosive oesophagitis
@en
prefLabel
Randomised phase 3 trial: tego ...... ents with erosive oesophagitis
@en
P2093
P50
P356
P1476
Randomised phase 3 trial: tego ...... ents with erosive oesophagitis
@en
P2093
Bong Tae Kim
Chi Hye Park
Geun Seog Song
Hyo Ju Park
In-Kyung Sung
Jin Il Kim
Jong Hyeok Kim
Joon Seong Lee
Joong Goo Kwon
Kwang Jae Lee
P304
P356
10.1111/APT.15185
P50
P577
2019-03-06T00:00:00Z